LGC Acquires SeraCare Life Sciences, Expands Into Clinical Quality Control Market
(GenomeWeb) – LGC announced today that it has acquired SeraCare Life Sciences, a provider of quality control materials for the infectious disease testing and next-generation sequencing markets.
According to LGC, the acquisition strengthens the firm's position across the clinical quality control tools market and expands its calibration verification materials and proficiency testing offerings.